SCHEMBL4750423

SCHEMBL4750423

NC(CF)Cc1ccc(-c2cccnc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.58
MKNK1 Q9BUB5 5/20 0.54
MKNK2 Q9HBH9 5/20 0.54
CYP3A4 P08684 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
CYP11B2 P19099 3/20 0.42
KIF11 P52732 1/20 0.42
ELOVL1 Q9BW60 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
CYP19A1 P11511 2/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDR P35968 2/20 0.41
TEK Q02763 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14024057 1.00 CYP2A6 (0.58) CYP2A6MKNK1MKNK2CYP3A4ALDH1A1
SCHEMBL13878057 0.81 CYP2A6 (0.67) CYP2A6MKNK1MKNK2CYP3A4ALDH1A1
SCHEMBL14023976 0.78 WNT3A (0.38) CYP2A6
SCHEMBL3756927 0.77 CYP2A6 (0.57) CYP2A6MKNK1MKNK2CYP3A4ALDH1A1
SCHEMBL19063000 0.77 CYP2D6 (0.43) CA12CA1CA2CA9CYP19A1
SCHEMBL12413787 0.77 MKNK1 (0.61) CYP2A6MKNK1MKNK2CYP3A4ALDH1A1
SCHEMBL2433624 0.76 MKNK1 (0.49) CYP2A6MKNK1MKNK2CYP11B2CYP19A1
SCHEMBL7606896 0.76 SLC7A5 (0.56) CYP2A6MKNK1MKNK2CYP1A2
SCHEMBL21690091 0.76 SLC7A5 (0.56) CYP2A6MKNK1MKNK2CYP1A2
SCHEMBL353300 0.76 SLC7A5 (0.56) CYP2A6MKNK1MKNK2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934238-B1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MELINTA THERAPEUTICS INC (US) 2017-06-28 EP disclosed
WO-2008143729-A2 MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2008-11-27 WO disclosed